nach oben

European Radiology

Erschienen in:

01.04.2007 | Vascular-Interventional

Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update

verfasst von: Thomas J. Vogl, Stephan Zangos, Katrin Eichler, Danny Yakoub, Mohamed Nabil

Erschienen in: European Radiology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Liver metastasis is one of the main problems encountered in colorectal cancer management as the liver is the most common metastatic site. Several treatment options are available, among which transarterial chemotherapy has proved effective in achieving some local tumour control, improving the quality of life through symptomatic control as well as survival time. The present paper is intended to provide an overview of the techniques, indications and results of regional chemotherapy, which comprises transarterial chemoembolization (TACE) and chemoperfusion. This treatment approach has symptomatic, palliative, adjuvant and potentially curative objectives. We reviewed the studies involving TACE and chemoperfusion of colorectal liver metastases during the last few years to update the previous reviews published on this subject. The results achieved were so variable, due to the variations in patient selection criteria and regimens used between the different studies. The median survival ranged from 9 to 62 months and the morphological response ranged from 14 to 76%. Technical aspects, results, and complications of this modality will be demonstrated with a detailed analysis and comments.

Pickren JW, Tsukada Y, Lane WW (1982) Liver metastasis. In: Weiss L, Gilbert HA (eds) Analysis of autopsy data. GK Hall, Boston, pp 2–18

Vogl TJ, Zangos S, Balzer JO, Thalhammer A, Mack MG (2002) Transarterial chemoembolization of liver metastases: indication, technique, results. Röfo 174(6):675–683PubMed

Cohen AD, Kemeny NE (2003) An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8(6):553–566PubMedCrossRef

Ji SH, Park YS, Lee J, Lim do H, Park BB, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K (2005) Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. Jpn J Clin Oncol 35(4):214–217PubMedCrossRef

Kuehr T, Ruff P, Rapoport BL, Falk S, Daniel F, Jacobs C, Davidson N, Thaler J, Boussard B, Carmichael J (2004) Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer. BMC Cancer 4:36PubMedCrossRef

Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S (2005) Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol 22(23):4753–4761; erratum: J Clin Oncol 23(1):248CrossRef

Hofheinz RD, Gnad-Vogt U, Wein A, Saussele S, Kreil S, Pilz L, Hehlmann R, Hochhaus A (2005) Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study. Anticancer Drugs 16(1):39–45PubMedCrossRef

Germer CT, Buhr HJ, Isbert C (2005) Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment. Chirurg 76(6):552–563PubMedCrossRef

Vogl TJ, Straub R, Eichler K, Söllner O, Mack MG (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy—local tumor control rate and survival data. Radiology 230(2):450–458PubMedCrossRef

10.

Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS (2001) Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221(1):159–166PubMedCrossRef

11.

Burdio F, Navarro A, Sousa R, Burdio JM, Guemes A, Gonzalez A, Cruz I, Castiella T, Lozano R, Berjano E, Figueras J, de Gregorio MA (2006) Evolving technology in bipolar perfused radiofrequency ablation: assessment of efficacy, predictability and safety in a pig liver model. Eur Radiol [epub ahead of print]

12.

Lee JM, Han JK, Kim SH, Lee JY, Park HS, Eo H, Choi BI (2005) Radiofrequency ablation in the liver using two cooled-wet electrodes in the bipolar mode. Eur Radiol 15(10):2163–2170PubMedCrossRef

13.

Sullivan RD, Norcross JW, Watkins E (1964) Chemotherapy for metastastic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 270:321–327PubMedCrossRef

14.

Herrmann KA, Waggershauser T, Sittek H, Reiser MF (2000) Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 215(1):294–299PubMed

15.

Tanaka T, Arai Y, Inaba Y, Matsueda K, Aramaki T, Takeuchi Y, Kichikawa K (2003) Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 14(1):63–68PubMed

16.

Irie T (2001) Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modified fixed catheter tip technique. J Vasc Interv Radiol 12(10):1215–1218PubMedCrossRef

17.

Venturini M, Angeli E, Salvioni M, De Cobelli F, Ronzoni M, Aldrighetti L, Stella M, Carlucci M, Staudacher C, Di Carlo V, Ferla G, Villa E, Del Maschio A (2004) Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. AJR Am J Roentgenol 182(6):1417–1426PubMed

18.

Link KH, Kornmann M, Formentini A, Leder G, Sunelaitis E, Schatz M, Pressmar J, Beger HG (1999) Regional chemotherapy of nonresectable liver metastases from colorectal cancer - literature and institutional review. Langenbecks Arch Surg 384(4):344–353PubMedCrossRef

19.

Nelson RL, Freels S (2004) A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis Colon Rectum 47(5):739–745PubMedCrossRef

20.

Clancy TE, Dixon E, Perlis R, Sutherland FR, Zinner MJ (2005) Hepatic arterial infusion after curative resection of colorectal cancer metastases: a metaanalysis of prospective clinical trials. J Gastrointest Surg 9(2):198–206PubMedCrossRef

21.

Ohtsuka Y, Matsunaga T, Yoshida H, Kouchi K, Okada T, Ohnuma N (2004) Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma. Surg Today 34(2):127–133PubMedCrossRef

22.

Fiorentini G, Rossi S, Bonechi F, Vaira M, De Simone M, Dentico P, Bernardeschi P, Cantore M, Guadagni S (2004) Intraarterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study. J Chemother 16(3):293–297PubMed

23.

Kress O, Wagner HJ, Wied M, Klose KJ, Arnold R, Alfke H (2003) Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - a retrospective single-center analysis. Digestion 68(2–3):94–101PubMedCrossRef

24.

Wasser K, Giebel F, Fischbach R, Tesch H, Landwehr P (2005) Transcatheter arterial chemoembolization of colorectal liver metastases using degradable starch microspheres (Spherex (R)). Own investigations and review to the literature. [German] Radiologe 45(7):633–643PubMedCrossRef

25.

Ruszniewski P, O’Toole D (2004) Ablative therapies for liver metastases of gasteroenteropathic endocrine tumors. Neuroendocrinology 80 (suppl 1):74–78PubMedCrossRef

26.

Popov I, Lavrnic S, Jelic S, Jezdic S, Jasovic A (2002) Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit. Neoplasma 49(1):43–48PubMed

27.

Muller H, Nakchbandi V, Chatzisavvidis I, von Voigt C (2003) Repetitive chemoembolization with melphalan plus intraarterial immunochemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Hepatogastroenterology 50(54):1919–1926PubMed

28.

Schell SR, Camp ER, Caridi JG, Hawkins IF (2002) Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg 6(5):664–670PubMedCrossRef

29.

Loewe C, Schindl M, Cejna M, Niederle B, Lammer J, Thurnher S (2003) Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 180(5):1379–1384PubMed

30.

Hunt TM, Flowerdew AD, Birch SJ, Williams JD, Mullee MA, Taylor I (1990) Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 77(7):779–782PubMedCrossRef

31.

Martinelli DJ, Wadler S, Bakal CW, Cynamon J, Rozenblit A, Haynes H, Kaleya R, Wiernik PH (1994) Utility of embolization or chemoembolization as second-line treatment in patients with advances or recurrent colorectal carcinoma. Cancer 74(6):1706–1712PubMedCrossRef

32.

Salman HS, Cynamon J, Jagust M, Bakal C, Rozenblit A, Kaleya R, Negassa A, Wadler S (2002) Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2(3):173–179PubMedCrossRef

33.

Agarwala SS, Panikkar R, Kirkwood JM (2004) Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 14(3):217–222PubMedCrossRef

34.

Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS (1995) Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 76(9):1665–1670PubMedCrossRef

35.

Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA (2003) Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 9(4):261–267PubMedCrossRef

36.

Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, Ducreux M (2003) Transcatheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13(1):136–140PubMed

37.

Tarazov PG (2000) Transcatheter therapy of gastric cancer metastatic to the liver: preliminary results. J Gastroenterol 35(12):949–950CrossRef

38.

Taniguchi H, Takahashi T, Sawai K, Yamaguchi T, Hagiwara A, Kitamura K et al (1997) Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hepatogastroenterology 44(15):897–900PubMed

39.

Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M (1999) A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group. Jpn J Clin Oncol 29(1):23–27PubMedCrossRef

40.

Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD (2001) Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 6(1):25–28PubMedCrossRef

41.

Arai Y, Endo T, Sone Y, Tohyama N, Inaba Y, Kohno S et al (1992) Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system. Cancer Chemother Pharmacol 31 [Suppl 1]:99–102CrossRef

42.

Yoon SS, Tanabe KK (1999) Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 4(3):197–208PubMed

43.

Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangod S (2003) Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 229(2):457–464PubMedCrossRef

44.

Vogl TJ, Mack MG, Müller PK, Straub R, Engelmann K, Eichler K (1999) Interventional MR: interstitial therapy. Eur Radiol 9(8):1479–1487PubMedCrossRef

45.

Yamagami T, Kato T, Tanaka O, Hirota T, Nishimura T (2005) Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 16(4):549–554PubMed

46.

Barber FD, Mavligit G, Kurzrock R (2004) Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev 30(5):425–436PubMedCrossRef

47.

Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M (2005) Gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23(22):4881–4887PubMedCrossRef

48.

Kemeny N, Jarnagin W, Paty P, Gonen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23(22):4888–4896PubMedCrossRef

49.

Durand-Zaleski I, Earlam S, Fordy C, Davies M, Allen-Mersh TG (1998) Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Cancer 83(5):882–888PubMedCrossRef

50.

Durand-Zaleski I, Roche B, Buyse M, Carlson R, O’Connell MJ, Rougier P, Chang AE, Sondak VK, Kemeny MM, Allen-Mersh TG, Fagniez PL, Le Bourgeois JP, Piedbois P (1997) Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst 89(11):790–795PubMedCrossRef

51.

Abramson RG, Rosen MP, Perry LJ, Brophy DP, Raeburn SL, Stuart KE (2000) Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 216(2):485–491PubMed

52.

Yoshikawa M, Ebara M, Nakano T, Minoyama A, Sugiura N, Ohto M (1992) Percutaneous transaxillary catheter insertion for hepatic artery infusion chemotherapy. AJR Am J Roentgenol 158(4):885–886PubMed

53.

Oi H, Kishimoto H, Matsushita M, Hori M, Nakamura H (1996) Percutaneous implantation of hepatic artery infusion reservoir by sonographically guided left subclavian artery puncture. AJR Am J Roentgenol 166(4):821–822PubMed

54.

Wacker FK, Boese-Landgraf J, Wagner A, Albrecht D, Wolf KJ, Fobbe F (1997) Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Interv Radiol 20(2):128–132CrossRef

55.

Zanon C, Grosso M, Clara R et al (2001) Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Am J Clin Oncol 24(4):354–359PubMedCrossRef

56.

Jung HY, Shim HJ, Kwak BK et al (1999) Percutaneously implantable catheter-port system for chemotherapeutic infusion through the hepatic artery. AJR Am J Roentgenol 172(3):641–644PubMed

57.

Kuroiwa T, Honda H, Yoshimitsu K et al (2001) Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol 24(2):90–93PubMedCrossRef

58.

Lorenz M, Mueller HH, Mattes E, Gassel HJ, Junginger T, Saeger HD, Schramm H, Staib-Sebler E, Vetter G, Heinrich S, Kohne CH (2001) German Cooperative Group on Liver Metastases (Arbeitsgruppe Lebermetastasen und -tumoren (ALM) in der Chirurgischen Arbeitsgemeinschaft Onkologie) Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Ann Oncol 12(3):321–325PubMedCrossRef

59.

Okamoto N, Maruta M, Maeda K, Sato H, Takizawa K, Masumori K, Aoyama H, Kato R (2003) Clinical outcome of intra-hepatic arterial infusion therapy for multiple liver metastases from colorectal cancer Gan To Kagaku Ryoho 30(4):501–504PubMed

60.

Tono T, Hasuike Y, Ohzato H, Takasuka Y, Kikkawa N (2000) Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Cancer 88:1549–1556PubMedCrossRef

61.

Fiorentini G, Rossi S, Dentico P, Bernardeschi P, Calcinai A, Bonechi F, Cantore M, Gaudagni S, De Simone M (2003) Irinotecan hepatic arterial infusion chenotherapy for hepatic metastases from colorectal cancer: a phase II clinical study. Tumori J 89(4):382–384

62.

Fazio N, Orsi F, Grasso RF, Ferretti G, Medici M, Rocca A, Zampino G, Curigliano G, De Pas T, Colleoni M, Bonomo G, Marrocco E, Lunghi L, De Braud F (2003) Hepatic intraarterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma. Anticancer Res 23(6D):5023–5030PubMed

63.

Oberfield RA, Sampson E, Heatley GJ (2004) Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement. Am J Clin Oncol 27(4):376–383PubMedCrossRef

64.

Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P (2005) Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91(2):97–101PubMedCrossRef

65.

Voigt W, Behrmann C, Schlueter A, Kegel T, Grothey A, Schmoll HJ (2002) A new chemoembolization protocol in refractory liver metastasis of colorectal cancer: a feasibility study. Onkologie 25(2):158–164PubMedCrossRef

Titel: Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update
verfasst von: Thomas J. Vogl
Stephan Zangos
Katrin Eichler
Danny Yakoub
Mohamed Nabil
Publikationsdatum: 01.04.2007
Verlag: Springer-Verlag
Erschienen in: European Radiology / Ausgabe 4/2007
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-006-0372-5

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update

Abstract

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2007

Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry

Assessment of regional left ventricular function with multidetector-row computed tomography versus magnetic resonance imaging

Quantitative and qualitative characterization of vascularization and hemodynamics in head and neck tumors with a 3D magnetic resonance time-resolved echo-shared angiographic technique (TREAT)—initial results

Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils

Tuberculous adenitis: comparison of CT and MRI findings with histopathological features

Dissection of the V4 segment of the vertebral artery: clinicoradiologic manifestations and endovascular treatment

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie